Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MC4R | P32245 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 5/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7950846 | 0.76 | CYP2D6 (0.44) | MEN1KMT2AHSD17B10HPGDCYP2D6 | |
| SCHEMBL8151923 | 0.67 | MEN1 (0.50) | MEN1KMT2AHSD17B10HPGDCYP2D6 | |
| SCHEMBL3841981 | 0.67 | KDM4E (0.31) | HPGDALDH1A1KDM4E | |
| SCHEMBL818809 | 0.66 | CYP2D6 (0.34) | HPGDCYP2D6 | |
| SCHEMBL27881082 | 0.65 | MEN1 (0.47) | MEN1KMT2AHSD17B10HPGDCYP2D6 | |
| SCHEMBL10400587 | 0.65 | MEN1 (0.47) | MEN1KMT2AHSD17B10HPGDCYP2D6 | |
| SCHEMBL1006344 | 0.64 | — | — | |
| Carbon Monoxide SCHEMBL8145637 | 0.63 | MEN1 (0.46) | MEN1KMT2AHSD17B10HPGDCYP2D6 | |
| SCHEMBL28784153 | 0.62 | BRD4 (0.48) | MEN1KMT2AHSD17B10HPGDCYP2D6 | |
| Efetozole SCHEMBL21698044 | 0.62 | BRD4 (0.51) | MEN1KMT2AHSD17B10HPGDCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150038723-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2015-02-05 | — | — | US | disclosed |
| US-8153810-B2 | Alkylidene complexes of ruthenium containing N-heterocyclic carbene ligands; use as highly active, selective catalysts for olefin metathesis | EVONIK DEGUSSA GMBH (DE) | 2012-04-10 | — | — | US | disclosed |
| US-20110282068-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2011-11-17 | — | — | US | disclosed |
| US-20080207911-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | EVONIK DEGUSSA GMBH (DE) | 2008-08-28 | — | — | US | disclosed |
| US-7378528-B2 | Alkylidene complexes of ruthenium containing N-heterocyclic carbene ligands; use as highly active, selective catalysts for olefin metathesis | EVONIK DEGUSSA GMBH (DE) | 2008-05-27 | — | — | US | disclosed |
| US-20080009598-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | DEGUSSA AG (DE) | 2008-01-10 | — | — | US | disclosed |
| EP-1087838-B1 | ALKYLIDENE COMPLEXES OF RUTHENIUM WITH N-HETEROCYCLIC CARBENE LIGANDS AND THEIR USE AS CATALYSTS FOR OLEFIN METATHESIS | DEGUSSA (DE) | 2005-05-25 | — | — | EP | disclosed |
| US-20050013150-A2 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | Aventis Research @$amp; Technologies GmbH @$amp; Co. KG (DE) | 2005-01-20 | — | — | US | disclosed |
| US-20040095792-A1 | Alkylidene complexes of ruthenium containing N-heterocyclic carbene ligands; use as highly active, selective catalysts for olefin metathesis | HERRMANN WOLFGANG ANTON (DE) | 2004-05-20 | — | — | US | disclosed |
| US-6635768-B1 | Inexpensive, highly active catalysts; high tolerance toward a variety of functional groups but also a wide range of possible variations in the ligand sphere | DEGUSSA AG (DE) | 2003-10-21 | — | — | US | disclosed |
| EP-1087838-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM WITH N-HETEROCYCLIC CARBENE LIGANDS AND THEIR USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | Aventis Research & Technologies GmbH & Co. KG (DE) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999051344-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM WITH N-HETEROCYCLIC CARBENE LIGANDS AND THEIR USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282068-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | CBR1, NR2E1, OXER1 | MEN1 978/4885KMT2A 4210/4885HSD17B10 1874/4885 |
| US-20150038723-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | OXER1, CBR1, AKR1C4 | MEN1 1333/4885KMT2A 3240/4885HSD17B10 1421/4885 |
| US-20080207911-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | CBR1, NR2E1, OXER1 | MEN1 911/4885KMT2A 4198/4885HSD17B10 1882/4885 |
| US-20080009598-A1 | ALKYLIDENE COMPLEXES OF RUTHENIUM CONTAINING N-HETEROCYCLIC CARBENE LIGANDS; USE AS HIGHLY ACTIVE, SELECTIVE CATALYSTS FOR OLEFIN METATHESIS | CBR1, NR2E1, OXER1 | MEN1 911/4885KMT2A 4198/4885HSD17B10 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.